Inherited predisposition to cancer: Introduction and overview

Hematology/Oncology Clinics of North America

Volumn 24, Issue 5, 2010, Pages 793-797

  Robson, Mark ^a,b   Offit, Kenneth ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cancer; Genetic predisposition; High penetrance; History

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

BREAST CANCER; CANCER GENETICS; CANCER RESEARCH; CANCER SUSCEPTIBILITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN; MELANOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASTIC SYNDROMES, HEREDITARY; PRACTICE GUIDELINES AS TOPIC;

EID: 77956305912     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2010.06.005     Document Type: Review

References (17)

1. Broca P. Traité des tumeurs: Tome Premier, Des tumeurs en général. In: Asselin P, editor. Paris; 1866. Available at: Accessed June 4, 2010. http://www.archive.org/stream/traitdestumeurs02brocgoog#page/n12/mode/1up.
2. Warthin A.S. Heredity with reference to carcinoma as shown by the study of cases examined in the pathological laboratory of the University of Michigan, 1895-1913. Arch Intern Med 1913, 12:546-555.
3. Dukes C., Lockhart-Mummery H. Familial intestinal polyposis. Surg Clin North Am 1955, 1277-1281.
4. Lynch H.T., Krush A.J. Cancer family " G" revisited: 1895-1970. Cancer 1971, 27(6):1505-1511.
5. Li F.P., Fraumeni J.F. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 1969, 43(6):1365-1373.
6. Lynch H.T., Krush A.J. Carcinoma of the breast and ovary in three families. Surg Gynecol Obstet 1971, 133(4):644-648.
7. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68(4):820-823.
8. Bailey-Wilson J.E., Elston R.C., Schuelke G.S., et al. Segregation analysis of hereditary nonpolyposis colorectal cancer. Genet Epidemiol 1986, 3(1):27-38.
9. Newman B., Austin M.A., Lee M., et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A 1988, 85(9):3044-3048.
10. Offit K., Biesecker B., Burt R., et al. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol 1996, 14(5):1730-1736. [discussion: 1737-40].
11. Offit K. Clinical cancer genetics; risk counseling and management 1998, Wiley-Liss, New York.
12. Teutsch S.M., Bradley L.A., Palomaki G.E., et al. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group. Genet Med 2009, 11(1):3-14.
13. Fong P.C., Boss D.S., Yap T.A., et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009, 361(2):123-134.
14. Byrski T., Gronwald J., Huzarski T., et al. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol 2010, 28(3):375-379.
15. Offit K. Genomic profiles for disease risk: predictive or premature?. JAMA 2008, 299(11):1353-1355.
16. Robson M.E., Storm C.D., Weitzel J., et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010, 28(5):893-901.
17. Offit K., Sagi M., Hurley K. Preimplantation genetic diagnosis for cancer syndromes: a new challenge for preventive medicine. JAMA 2006, 296(22):2727-2730.